Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2022

Aug 01, 2022

SELL
$117.13 - $176.59 $655,928 - $988,904
-5,600 Reduced 71.79%
2,200 $314,000
Q1 2022

Apr 27, 2022

BUY
$126.46 - $235.05 $986,388 - $1.83 Million
7,800 New
7,800 $1.34 Million
Q4 2021

Jan 31, 2022

SELL
$225.82 - $368.51 $519,386 - $847,573
-2,300 Closed
0 $0
Q3 2021

Nov 02, 2021

BUY
$221.9 - $484.47 $510,370 - $1.11 Million
2,300 New
2,300 $883,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Qvr LLC Portfolio

Follow Qvr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qvr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Qvr LLC with notifications on news.